Laura Orthwein

FOUNDER & CEO

Cross-sector entrepreneur with a track record of scaling innovation in healthcare, defense, and digital transformation. Led strategy engagements for Merck and secured sole-source military contracts for proprietary technologies. Now spearheading Avalyra’s vision to transform diagnostics through real-time biophotonic sensing.

Dr. Charles Peterson

MD, MBA

CHEIF MEDICAL OFFICER

Former NIH Division Director and national leader in hematologic innovation. Guided federal research on sickle cell disease and non-invasive diagnostics. Now shaping Avalyra’s clinical strategy and trial design for high-impact deployment.

Dr. Joseph Chaiken

PhD

LEAD SCIENTIFIC ADVISOR

Inventor of Avalyra’s patented biophotonic platform. Physicist and pioneer in real-time vascular diagnostics, with decades of NIH and DoD-funded research in spectroscopy and signal fidelity. Oversees scientific direction and signal algorithm development.

Dr. Paul Dent,

PhD

SENIOR R&D SCIENTIST, PRODUCT DEVELOPMENT

Co-inventor of Avalyra’s sensing platform and lead engineer for device miniaturization. Specializes in analog/digital integration, prototyping, and system calibration from lab to field.